XENOTHERA to raise Series A

XENOTHERA to raise Series A

Xenothera has started to gather investors for a Series A round of funding that will occur in 2019.

This upcoming round will finance an highly anticipated first-in-human trial that will start this year. After amazing pre-clinical and toxicology data in 2018, Xenothera’s LIS1 is ready for clinical tests. As per the nature of the product there will be no phase I and we are excited to jump onto the phase II.

Stay tuned for the upcoming publications regarding pre-clinical analysis.

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Ce site utilise Akismet pour réduire les indésirables. En savoir plus sur comment les données de vos commentaires sont utilisées.